1 / 8

Anticoagulation and AF: Emerging Insights

Anticoagulation and AF: Emerging Insights. Professor the Lord Kakkar Thrombosis Research Institute and University College London. Register of Interests for Ajay Kakkar. The Global Anticoagulant Registry in the Field: Ongoing representative, worldwide outcomes research programme.

cybil
Download Presentation

Anticoagulation and AF: Emerging Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Anticoagulation and AF:Emerging Insights Professor the Lord Kakkar Thrombosis Research Institute and University College London

  2. Register of Interests for Ajay Kakkar

  3. The Global Anticoagulant Registry in the Field:Ongoing representative, worldwide outcomes research programme • Independent academic research initiative • 55,000 newly-diagnosed AF patients in 34 countries • Randomized selection of sites representative of national AF care settings • Unselected prospective patients enrolled consecutively • Long-term follow-up (minimum of 2 years, up to 8 years) • 5 sequential prospective cohorts • Extensive monitoring (20% of CRFs)

  4. The Global Anticoagulant Registry in the Field:Already one of the largest outcomes research programmes in AF • 34,205 AF patients recruited in 34 countries • 29,117 prospective patients • Cohort 3 recruitment completed July 2014 (n=11,405) • Cohort 4 recruitment opened August 2014 (n=456)

  5. Antithrombotic prescribing patterns in Garfield-AF Dec 09-Oct 11 Oct 11-Jun 13 Jun 13-Jun 14 Dec 09-Jun14 Preliminary data 30 June 2014 N=10,278 N=11,557 N=9831 N=31,666

  6. The use of NOACs has increased Dec 09-Oct 11 Oct 11-Jun 13 Jun 13-Jun 14 Dec 09-Jun13 Preliminary data 30 June 2014

  7. Acknowledgements This research programmewould not be possible without the hard work and dedication of the: • Steering Committee • National Coordinator Council • Garfield-AF Investigators

  8. Anticoagulation and AF: Emerging InsightsAgenda • Understanding risk, Professor Dan Atar • The role of anticoagulants, Professor Keith Fox • Preventing a second stroke, Professor John Camm • Lessons beyond AF, Professor Samuel Z Goldhaber • Future challenges, Professor Alexander GG Turpie • Panel discussion: Stroke prevention in AF 2014, Case Presenter: Professor Sylvia Haas Discussant: Dr Bernard J Gersh • Closing remarks, Professor Jean-Pierre Bassand

More Related